Covered recipient · General Payments record
IVAN N TRINH
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$3,948.32
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $450.61 | 21 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $132.54 | 1 |
| Amgen Inc. | $90.32 | 6 |
| Novo Nordisk AS | $43.13 | 3 |
| Astellas Pharma US Inc | $35.00 | 2 |
| Exeltis, USA Inc. | $31.48 | 2 |
| Organon LLC | $29.08 | 2 |
| ABBVIE INC. | $21.06 | 1 |
| Xeris Pharmaceuticals, Inc. | $19.95 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.14 | 1 |
| Sumitomo Pharma America, Inc. | $15.97 | 1 |
| GlaxoSmithKline, LLC. | $15.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (21)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.06 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243440 | CMS |
| Alexion Pharmaceuticals, Inc. | $132.54 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093910747 | CMS |
| Amgen Inc. | $14.00 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111727741 | CMS |
| Amgen Inc. | $16.37 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402000 | CMS |
| Amgen Inc. | $17.71 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111727743 | CMS |
| Amgen Inc. | $14.21 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402002 | CMS |
| Amgen Inc. | $13.78 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111727745 | CMS |
| Amgen Inc. | $14.25 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402004 | CMS |
| Astellas Pharma US Inc | $17.26 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139296070 | CMS |
| Astellas Pharma US Inc | $17.74 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139329998 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.14 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086170906 | CMS |
| Exeltis, USA Inc. | $13.50 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150006322 | CMS |
| Exeltis, USA Inc. | $17.98 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150006324 | CMS |
| GlaxoSmithKline, LLC. | $15.94 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115929575 | CMS |
| Novo Nordisk Inc | $13.63 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097568126 | CMS |
| Novo Nordisk Inc | $14.59 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096968287 | CMS |
| Novo Nordisk Inc | $14.91 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096792728 | CMS |
| Organon Llc | $10.19 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136187412 | CMS |
| Organon Llc | $18.89 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136187414 | CMS |
| Sumitomo Pharma America, Inc. | $15.97 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148929376 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.95 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144597120 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.